Evidence map›Paper›PMID 42588489›Full record

ReviewMolecules (Basel, Switzerland)2026

LC-HRMS and Molecular Networking for Non-Targeted Screening of Emerging Contaminants in Cosmetics: Workflow, Applications, and Regulatory Challenges.

Linrui Fu, Yike Song, Jie Zhu, Haiyan Wang, Yong Lu

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Linrui FuNational Institute for Food and Drug Control, Beijing 100050, China.
Yike SongNational Institute for Food and Drug Control, Beijing 100050, China.
Jie ZhuNational Institute for Food and Drug Control, Beijing 100050, China.
Haiyan WangNational Institute for Food and Drug Control, Beijing 100050, China.ORCID 0000-0001-5662-6596
Yong LuNational Institute for Food and Drug Control, Beijing 100050, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Emerging contaminants (ECs) in cosmetics are introduced through various pathways, including illegal adulteration, raw material impurities, and packaging migration. Characterized by chronic exposure, potential toxicity, and an elusive nature, these contaminants pose a continuous and serious threat to public health. Currently, the regulatory control of ECs in the cosmetics industry is still evolving. Traditional targeted analysis, which relies heavily on predefined reference lists and standards, suffers from narrow coverage and fails to meet modern safety requirements for the comprehensive screening and early warning of ECs. To address this challenge, liquid chromatography-high-resolution mass spectrometry (LC-HRMS), combined with non-targeted screening (NTS) strategies and molecular networking (MN), serves as a powerful analytical tool. By operating in a full-scan mode without predefined targets, this technology comprehensively captures thousands of chemical features in cosmetic samples, enabling the prioritization and tentative annotation of concealed risk substances for subsequent structural confirmation. Furthermore, the spectral similarity clustering capability of MN facilitates the identification of homologous derivatives and structural analogs from a single known compound, significantly enhancing the efficiency and systematic discovery of ECs. From a regulatory perspective, this integrated approach provides crucial technical support for authorities to accurately assess risks and ensure consumer safety. Ultimately, it promotes a paradigm shift in cosmetic safety management, from a passive response to known hazards to the proactive prevention and control of emerging risks.

Indexed as

CosmeticsLiquid Chromatography-Mass SpectrometryChromatography, LiquidHumansMass SpectrometryWorkflowCosmeticscosmetic safetyemerging contaminantshigh-resolution mass spectrometrymolecular networknon-targeted screening

Identifiers

PMID42588489
PMCPMC13467950

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.